metformin vs glp 1 for pcos use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges - Saadati - 2025 - Diabetes, Obesity and Metabolism Expanding therapeutic horizons: glucagon-like peptide-1

Semaglutide is a GLP-1 receptor agonist, a prescription medication that lowers blood sugar and red

According to their findings, 53.6% discontinued GLP-1 treatment by the end of year one, with higher rates of discontinuation (64.8%) seen among those using the drugs solely for weight loss, when compared with the 46.5% of those who quit after using the medications as a diabetes treatment

Only actual behavior and lifestyle changesincluding eating a metabolically healthy diet and incorporating regular exercisecan produce lasting and effective health outcomes

Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond

Recent Developments/ Strategic Initiatives 8.5.4

For any questions, please refer to the original English version.